Breast cancer metastasis to the bone: mechanisms of bone loss
Year: 2010
Type: review
Abstract: Breast cancer frequently metastasizes to the skeleton, interrupting the normal bone remodeling process and causing bone degradation. Osteolytic lesions are the end result of osteoclast activity; however, osteoclast differentiation and activation are mediated by osteoblast production of RANKL (receptor activator for NFκB ligand) and several osteoclastogenic cytokines. Osteoblasts themselves are negatively affected by cancer cells as evidenced by an increase in apoptosis and a decrease in proteins required for new bone formation. Thus, bone loss is due to both increased activation of osteoclasts and suppression of osteoblasts. This review summarizes the current understanding of the osteolytic mechanisms of bone metastases, including a discussion of current therapies.
Source: Breast Cancer Research
DOI: 10.1186/bcr2781
Authors: Yu-Chi Chen, Donna M Sosnoski, Andrea M Mastro
Institution: Pennsylvania State University
Language: English
Topic: Bone Metabolism and Diseases
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,190
Award: G1726178786
OpenAlex ID: W2132311567
